Resolution Therapeutics has expanded its regenerative macrophage therapy pipeline with [...]

CERo Therapeutics Holdings, Inc has shared a Phase 1 update [...]

Cellares has secured a $50 million growth equity investment from [...]

Context Therapeutics has reported encouraging interim Phase 1 data for [...]

VIVEbiotech has expanded its in vivo lentiviral vector portfolio to [...]

Vertex Pharmaceuticals has presented new Phase 3 data showing positive [...]

OrganaBio has entered a manufacturing partnership with RxMP Therapeutics to [...]

Cellares has expanded its Series D financing to $277 million [...]

Cartesian Therapeutics has signed a strategic licensing agreement with WestGene [...]

CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]